Clore and Ottensmann explain: Synthetic biology is revolutionizing medical treatments for a wide range of diseases. It’s what made it possib...
Approval underscores CSL and Arcturus Therapeutics' commitment to delivering disruptive technologies to combat COVID-19 and other respiratory viral disea...
Boehringer Ingelheim said it has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines to address ch...
Thermo Fisher Scientific, the world leader in serving science, has announced the opening of a new Global Business Services Center (GBSC) in the P...
MyClad is a global Phase III study evaluating the efficacy and safety of cladribine capsules for the treatment of generalized Myasthenia Gravis (...
PfizerForAll makes managing everyday health quicker and more convenient for millions of Americans Platform is designed for patients with migraine, C...
Indian Union Cabinet, chaired by Prime Minister Shri Narendra Modi, recently approved the BioE3 (Biotechnology for Economy, Environment, and Empl...
Agilent Technologies Inc., announced the release of its new Agilent J&W 5Q GC/MS Columns, representing a major advance in gas chromatogra...
Partnership Expands Reach of C2N’s Precivity™ Blood Tests in Over 75 Countries to Transform Alzheimer’s Disease Early Diagnosis...
-Parse Biosciences, a leading provider of cost-effective and scalable solutions for single-cell sequencing, today announced an agreement with the Taiwane...
To enable pharmaceutical researchers to move quickly into their high‑throughput screening experiments, global genomics solutions provider Integrated DNA ...
Kiromic BioPharma, reports favorable eight-month follow-up results from the first patient enrolled in its Deltacel-01 Phase 1 clinical trial. This trial ...
Advances company’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing Mirus Bio’s leadin...
JelloX Biotech Inc. ('JelloX') is pleased to announce that it has entered into a collaboration through a know-how agreement with Mayo Cli...
© 2024 Biopharma Boardroom. All Rights Reserved.
